MedPath

State University of New York at Buffalo

State University of New York at Buffalo logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1846-05-11
Employees
1K
Market Cap
-
Website
http://www.buffalo.edu

Effects of a Lower Back Wrap Device on Lower Back Pain, Physical Function, and Quality of Life

Not Applicable
Recruiting
Conditions
Lower Back Pain
Lower Back Pain Chronic
Acute Low Back Pain
First Posted Date
2024-12-27
Last Posted Date
2024-12-27
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
150
Registration Number
NCT06749912
Locations
🇺🇸

University at Buffalo, Buffalo, New York, United States

Anomia Treatment Predictors

Not Applicable
Active, not recruiting
Conditions
Anomia (Word-Finding Impairment)
Aphasia
Interventions
Behavioral: Anomia Treatment
First Posted Date
2024-10-01
Last Posted Date
2024-12-10
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
2
Registration Number
NCT06619756
Locations
🇺🇸

UB Audiology and Speech-Language Pathology Clinic, Buffalo, New York, United States

Work Design Interventions for Heat Resilience

Not Applicable
Not yet recruiting
Conditions
Hyperthermia
Fatigue; Heat
Work-Related Condition
Interventions
Behavioral: Self-paced work
Behavioral: Reduced-pace work
Behavioral: Increased-pace work
Behavioral: Additional rest breaks
First Posted Date
2024-09-19
Last Posted Date
2024-09-19
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
16
Registration Number
NCT06599788

Lithium for Parkinson's: an Extension Trial

Phase 1
Conditions
Parkinson Disease
Interventions
Dietary Supplement: Lithium aspartate
First Posted Date
2024-09-19
Last Posted Date
2024-10-28
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
35
Registration Number
NCT06592014
Locations
🇺🇸

UBMD Neurology, Williamsville, New York, United States

Project ASTHMA - Aligning With Schools To Help Manage Asthma and Decrease Health Inequities

Not Applicable
Recruiting
Conditions
Asthma in Children
Directly Observed Therapy
Interventions
Other: APP assessment and management of asthma
First Posted Date
2024-08-06
Last Posted Date
2024-11-21
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
400
Registration Number
NCT06539312
Locations
🇺🇸

University at Buffalo, Department of Pediatrics, Buffalo, New York, United States

Sevoflurane Concentrations in Children

First Posted Date
2024-07-19
Last Posted Date
2024-10-26
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
28
Registration Number
NCT06510803
Locations
🇺🇸

John R. Oishei Children's Hospital, Buffalo, New York, United States

PICU-related Sleep and Circadian Dysregulation Pilot Study

Not Applicable
Recruiting
Conditions
Sleep Disturbance
Children, Only
Circadian Dysrhythmia
Critical Illness
Interventions
Other: Daytime light exposure
Other: Daytime restricted feeding
First Posted Date
2024-07-17
Last Posted Date
2024-12-30
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
30
Registration Number
NCT06505447
Locations
🇺🇸

John R. Oishei Children's Hospital, Buffalo, New York, United States

Facilitated Telemedicine in the Catholic Health System

Not yet recruiting
Conditions
HCV
First Posted Date
2024-07-03
Last Posted Date
2024-11-28
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
200
Registration Number
NCT06483451

Predicting Responses to Exhausting, Prolonged, and Repeated Exercise Demands (PREPARED) for Heat

Not Applicable
Recruiting
Conditions
Fatigue; Heat
Hyperthermia
Interventions
Other: 30/30 work/rest cycle
Other: 30/20 work/rest cycle
Other: 40/30 work/rest cycle
Other: 20/12 work/rest cycle
First Posted Date
2024-06-26
Last Posted Date
2024-12-20
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
24
Registration Number
NCT06475339
Locations
🇺🇸

Center for Research and Education in Special Environments, Buffalo, New York, United States

Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)

Phase 2
Not yet recruiting
Conditions
Multiple Sclerosis
Interventions
Drug: Placebo
Drug: metformin
First Posted Date
2024-06-18
Last Posted Date
2024-10-28
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
30
Registration Number
NCT06463743
© Copyright 2025. All Rights Reserved by MedPath